Stocktoria
Glass House Brands Inc. GLAS
Glass House Brands Inc. (GLAS) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $182.0M at a -16.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.27 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.094 |
| Retained earnings / assets | -0.691 |
| EBIT / assets | -0.052 |
| Equity / liabilities | 0.514 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| GLAS | Glass House Brands Inc. | 3/9 | -1.45 | — | -9.4% |
| BTMD | biote Corp. | 5/9 | 0.92 | 2.5 | -2.5% |
| CRON | Cronos Group Inc. | 6/9 | — | — | +19.5% |
| MRMD | MARIMED INC. | 4/9 | -1.76 | — | +1.3% |
| NAII | NATURAL ALTERNATIVES INTERNATIONAL INC | 5/9 | 3.07 | — | +14.1% |
| NAGE | Niagen Bioscience, Inc. | 5/9 | 3.42 | 15.7 | +29.9% |
| MTEX | MANNATECH INC | 2/9 | -1.37 | — | -8.3% |
About Glass House Brands Inc.
Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. The Retail segment owns, and operates retail cannabis stores, and dispensary operation management services. The Wholesale Biomass segment includes propagation, nursery, flowering canopy, dries, processes, and distributes cannabis biomass. The Cannabis-Related Consumer Packaged Goods segment manufactures, extracts, infuse, conversion, packaging, and distributes cannabis products. The company cultivates, manufactures, and distributes cannabis bulk flowers and trims to wholesalers; and consumer packaged goods to third-party retail stores in California. It also offers raw cannabis, cannabis oil, and cannabis consumer goods; edibles; flower jars and bags; single, multi-pack, and infused pre-rolls; tinctures; biomass for distributors; and online payment processing, in-store pickup and home delivery services for adult-use and medicinal-use customers. The company serves its cannabis products under the Glass House Farms, PLUS, Allswell, REEFORM, and Mama Sue brand names. Glass House Brands Inc. was founded in 2015 and is headquartered in Long Beach, California.
FAQ
Is GLAS financially healthy?
Glass House Brands Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does GLAS pay a dividend?
No, Glass House Brands Inc. does not currently pay a dividend.
How profitable is GLAS?
In FY2025, Glass House Brands Inc. had a net margin of -16.3% and a return on equity of -40.1%.
What is the analyst price target for GLAS?
The average Wall-Street price target for Glass House Brands Inc. is $16.00, about 55.5% above the recent price, from 2 analysts (consensus: strong buy).
Is GLAS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Glass House Brands Inc.: a Piotroski F-score of 3/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.